Sonoma Pharmaceuticals Inc. - notizie pubblicate 116 - letture 1.365
SONOMA PHARMACEUTICALS INC.
Management Change/Compensation - Form 8-K
Item 5.02. departure of directors of certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. on december 29, 2023, ...
SONOMA PHARMACEUTICALS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
SONOMA PHARMACEUTICALS INC.
Material Agreement - Form 8-K
Item 1.01 entry into a material definitive agreement. on december 15, 2023, sonoma pharmaceuticals, inc. (the "company") entered into an equity distribution agreement (th ...
SONOMA PHARMACEUTICALS INC.
Supplemental Prospectus - Form 424B3
Filed pursuant to rule 424(b)(3) registration no. 333-275311 prospectus supplement (to prospectus dated november 22, 2023) up to $392,077 sonoma pharmaceuticals, inc. common stock ...
SONOMA PHARMACEUTICALS INC.
Supplemental Prospectus - Form 424B5
Filed pursuant to rule 424(b)(5) registration no. 333-275311 prospectus $51,300,000 sonoma pharmaceuticals, inc. common stock preferred stock debt securities warrants units we may, ...
SONOMA PHARMACEUTICALS INC.
Notice of Effectiveness - Form EFFECT
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: november 20, 2023 5:00 p.m. form: s-3 ci ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer sonoma pharmaceutica ...
SONOMA PHARMACEUTICALS INC.
Quarterly Report for Quarter Ending September 30, 2023 (Form 10-Q)
Table of contents united states securities and exchange commission washington, dc 20549 form 10-q ☒quarterly report pursuant to section 13 or 15(d) of the securities exchange act ...
SONOMA PHARMACEUTICALS INC.
Registration Statement - Specified Transactions - Form S-3
Table of contents as filed with the securities and exchange commission on november 3, 2023. registration no. 333- united states securities and exchange commission washington, dc 20 ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
November 3, 2023 sonoma pharmaceuticals announces u.s. launch of next generation advanced solution for pulse lavage irrigation at the symposium on advanced wound care fall conferen ...
SONOMA PHARMACEUTICALS INC.
Supplemental Prospectus - Form 424B4
Table of contents filed pursuant to rule 424(b)(4) registration no. 333-274582 8,500,000shares of common stock sonoma pharmaceuticals, inc. we are offering on a best efforts basis ...
SONOMA PHARMACEUTICALS INC.
Notice of Effectiveness - Form EFFECT
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: october 26, 2023 9:00 a.m. form: s-1 cik ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
October 26, 2023 sonoma pharmaceuticals, inc. announces pricing of $1.7 million public offering of common stock boulder, co / accesswire / october 26, 2023 /sonoma pharmaceuticals, ...
SONOMA PHARMACEUTICALS INC.
Amendment to Initial Registration Statement - Form S-1/A
Table of contents as filed with the securities and exchange commission on october 13, 2023. registration no. 333-274582 united states securities and exchange commission washington, ...
SONOMA PHARMACEUTICALS INC.
Amendment to Current Report - Form 8-K/A
Sonoma pharmaceuticals, inc. investor presentation october 2023 legal disclaimers investor presentation this communication is for informational purposes only. the information conta ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti